13F filer · CIK 1037792 ↗
Paradigm Capital Management Inc
You are looking at Q4 2024. See the latest, Q2 2026 →
Reported value
$2.16B
−4.2% on the quarter before
Positions
128
6 new · 7 sold out
Top 10
52.9%
of the value
Est. gain
−$42.0M
on stocks held all quarter
Est. return
−2.0%
on those stocks since Q3 2024
Positions as of Dec 31, 2024, from Paradigm Capital Management Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2024. Striped tiles are options.
Largest buys
Since Q3 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- American Woodmark Corporation~$24.0MNew · 0.0% → 1.1%+301,189 shares
- Enovis Corporation~$22.5MAdded · 0.0% → 1.1%+513,200 shares
- Integra Lifesciences Holdings Corp~$20.4MAdded · 0.4% → 1.5%+901,600 shares
- J Jill Group~$7.9MAdded · 0.7% → 1.2%+285,715 shares
- Cerence~$6.6MAdded · 0.2% → 0.9%+842,900 shares
- Penguin Solutions Inc~$5.9MAdded · 0.0% → 0.3%+306,000 shares
- Enviri Corp~$4.3MAdded · 1.8% → 1.6%+563,100 shares
- Pacs Group, Inc.~$4.2MNew · 0.0% → 0.2%+320,000 shares
- Angiodynamics, Inc.~$3.7MNew · 0.0% → 0.2%+404,001 shares
- Nn, Inc.~$3.5MAdded · 0.1% → 0.3%+1,080,755 shares
Largest sells
Since Q3 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- R1 Rcm, Inc New~$42.7MSold out · 1.9% → 0.0%−3,010,100 shares
- Axcelis Technologies~$22.6MCut · 2.2% → 0.5%−323,000 shares
- Aviat Networks Inc Com New~$15.3MCut · 1.0% → 0.1%−845,646 shares
- Semtech~$10.2MSold out · 0.5% → 0.0%−222,438 shares
- Calix Inc~$9.4MCut · 2.3% → 1.7%−269,900 shares
- Cohu Inc.~$7.0MCut · 0.8% → 0.6%−262,985 shares
- Trubridge, Inc.~$4.5MCut · 0.2% → 0.1%−228,889 shares
- Revvity Inc.~$3.8MCut · 0.3% → 0.1%−34,350 shares
- Orthopediatrics Corp~$3.1MCut · 0.2% → 0.0%−133,400 shares
- Beyond Inc Common Stock~$3.0MSold out · 0.1% → 0.0%−299,165 shares
Holdings
As of Dec 31, 2024. Changes are in shares against Sep 30, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ModineCOM · shares −0.06% · price −12.7% | 8.9% | $191.1M | −$27.8M | ||||||||
| BroadcomCOM · shares 0% · price +34.4% | 8.7% | $187.6M | +$48.0M | ||||||||
| Onto InnovationCOM · shares 0% · price −19.7% | 8.5% | $184.2M | −$45.2M | ||||||||
| FabrinetCOM · shares 0% · price −7.0% | 5.4% | $117.0M | −$8.8M | ||||||||
| Insight EnterprisesCOM · shares 0% · price −29.4% | 4.2% | $90.7M | −$37.7M | ||||||||
| Extreme NetworksCOM · shares −1.0% · price +11.4% | 4.0% | $86.9M | +$8.9M | ||||||||
| JabilCOM · shares −1.6% · price +20.1% | 3.8% | $82.4M | +$13.8M | ||||||||
| Globus MedicalCOM · shares −2.3% · price +15.6% | 3.6% | $78.5M | +$10.6M | ||||||||
| Ducommun IncCOM · shares −0.3% · price −3.3% | 3.2% | $69.0M | −$2.4M | ||||||||
| Veeco InstrumentsCOM · shares +0.01% · price −19.1% | 2.5% | $53.1M | −$12.5M | ||||||||
| EntegrisCOM · shares +0.4% · price −12.0% | 2.5% | $53.1M | −$7.2M | ||||||||
| Ensign Group, Inc.COM · shares −0.03% · price −7.6% | 2.1% | $45.9M | −$3.8M | ||||||||
| MimedxCOM · shares +0.5% · price +62.8% | 2.1% | $45.1M | +$17.3M | ||||||||
| EnersysCOM · shares +3.3% · price −9.4% | 2.0% | $44.2M | −$4.4M | ||||||||
| Orthofix Medical Inc.COM · shares −2.8% · price +11.8% | 2.0% | $43.4M | +$4.6M | ||||||||
| Summit Materials, Inc. Class ACOM · shares −0.1% · price +29.6% | 2.0% | $42.9M | +$9.8M | ||||||||
| Ribbon Communications IncCOM · shares −4.3% · price +28.0% | 2.0% | $42.2M | +$9.2M | ||||||||
| Calix IncCOM · shares −20% · price −10.1% | 1.7% | $36.9M | −$4.1M | ||||||||
| Enviri CorpCOM · shares +14% · price −25.5% | 1.6% | $34.5M | −$10.3M | ||||||||
| Concentrix CorpCOM · shares +2.7% · price −15.6% | 1.5% | $32.5M | −$5.8M | ||||||||
| Integra Lifesciences Holdings CorpCOM · shares +170% · price +24.8% | 1.5% | $32.5M | +$2.4M | ||||||||
| Tactile Systems TechnologyCOM · shares −0.2% · price +17.2% | 1.3% | $28.5M | +$4.2M | ||||||||
| J Jill GroupCOM · shares +45% · price +12.0% | 1.2% | $25.4M | +$1.9M | ||||||||
| Pennant Group Inc.COM · shares −0.04% · price −25.7% | 1.2% | $24.9M | −$8.6M | ||||||||
| American Woodmark CorporationCOM · shares New | 1.1% | $24.0M | — | ||||||||
| Total · 128 positions | 100% | $2.16B | −$42.0M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2024 to Q4 2024: 122 stocks held throughout, down $42.0M (−2.0%).
- Broadcom+$48.0M+34%
- Mimedx+$17.3M+63%
- Jabil+$13.8M+20%
- Globus Medical+$10.6M+16%
- Summit Materials, Inc. Class A+$9.8M+30%
- Enviri Corp−$10.3M−26%
- Veeco Instruments−$12.5M−19%
- Modine−$27.8M−13%
- Insight Enterprises−$37.7M−29%
- Onto Innovation−$45.2M−20%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $3.67B+41% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $2.61B+10% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $2.38B+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $2.31B+12% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $2.05B+14% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $1.80B−17% | SEC ↗ |
| Q4 2024 | Feb 18, 2025 | $2.16B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.25B+3% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.19B+5% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $2.09B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.92B+10% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.74B−0% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.75B+16% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $1.51B−0% | SEC ↗ |
| Q4 2022 | Feb 3, 2023 | $1.51B+9% | SEC ↗ |
| Q3 2022 | Oct 26, 2022 | $1.39B−6% | SEC ↗ |
| Q2 2022 | Aug 2, 2022 | $1.47B−20% | SEC ↗ |
| Q1 2022 | May 25, 2022 | $1.85B−17% | SEC ↗ |
| Q4 2021 | Feb 9, 2022 | $2.24B+15% | SEC ↗ |
| Q3 2021 | Nov 8, 2021 | $1.94B−7% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $2.08B+8% | SEC ↗ |
| Q1 2021 | May 5, 2021 | $1.93B+15% | SEC ↗ |
| Q4 2020 | Jan 20, 2021 | $1.67B+41% | SEC ↗ |
| Q3 2020 | Oct 20, 2020 | $1.19B+9% | SEC ↗ |
| Q2 2020 | Aug 3, 2020 | $1.09B+32% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $827.9M−36% | SEC ↗ |
| Q4 2019 | Feb 5, 2020 | $1.30B+16% | SEC ↗ |
| Q3 2019 | Nov 7, 2019 | $1.12B+2% | SEC ↗ |
| Q2 2019 | Aug 8, 2019 | $1.10B−4% | SEC ↗ |
| Q1 2019 | May 10, 2019 | $1.14B+12% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $1.02B−20% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $1.27B+3% | SEC ↗ |
| Q2 2018 | Aug 8, 2018 | $1.24B+5% | SEC ↗ |
| Q1 2018 | Apr 9, 2018 | $1.18B+1% | SEC ↗ |
| Q4 2017 | Feb 7, 2018 | $1.17B+2% | SEC ↗ |
| Q3 2017 | Nov 6, 2017 | $1.15B+4% | SEC ↗ |
| Q2 2017 | Aug 10, 2017 | $1.11B+5% | SEC ↗ |
| Q1 2017 | May 9, 2017 | $1.06B+3% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $1.03B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $953.0M+16% | SEC ↗ |
| Q2 2016 | Aug 9, 2016 | $820.6M−4% | SEC ↗ |
| Q1 2016 | May 12, 2016 | $858.8M | SEC ↗ |